600 ORAL Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (ACC), an interim safety analysis. a Dutch Colorectal Cancer Group (DCCG) phase III study

首页> 外文期刊>European Journal of Cancer Supplements >600 ORAL Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (ACC), an interim safety analysis. a Dutch Colorectal Cancer Group (DCCG) phase III study

【24h】

600 ORAL Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (ACC), an interim safety analysis. a Dutch Colorectal Cancer Group (DCCG) phase III study

机译：600口服凯培他滨，伊立替康和奥沙利铂序贯化疗与联合化疗在晚期大肠癌（ACC）中的随机研究，一项临时安全性分析。荷兰结肠直肠癌小组（DCCG）的III期研究

获取原文

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2005年第2期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献

1. Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study. [J] . Koopman M, Antonini NF, Douma J, Annals of oncology: official journal of the European Society for Medical Oncology . 2006,第10期

机译：卡培他滨，伊立替康和奥沙利铂序贯或联合化疗在晚期大肠癌中的随机研究，一项临时安全性分析。荷兰大肠癌小组（DCCG）的III期研究。
2. Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study [J] . M Koopman, NF Antonini, J Douma, Annals of Oncology . 2006,第10期

机译：卡培他滨，伊立替康和奥沙利铂序贯化疗与联合化疗在晚期大肠癌中的随机研究，一项临时安全性分析。荷兰结肠直肠癌小组（DCCG）的III期研究
3. 3015 ORAL Sequential vs. combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (ACC). A Dutch Colorectal Cancer Group (DCCG) phase III study [J] . M.Koopman, N.F.Antonini, J.Douma, European Journal of Cancer Supplements . 2007,第4期

机译：3015口服卡培他滨，伊立替康和奥沙利铂序贯联合化疗联合治疗晚期大肠癌（ACC）。荷兰结肠直肠癌小组（DCCG）的III期研究
4. Correlation study of (IL-17 , IL-17RA ) and some biochemical parameters with patients of iraq colorectal cancer after and before taking a dose of chemotherapy [C] . Mezher N. Moslem, A. F. Altaie International Conference on Materials Engineering and Science . 2020

机译：（IL-17，IL-17RA）与一些生物化学参数与伊拉克结肠直肠癌患者服用化疗的相关性研究
5. Use and outcomes of newer chemotherapeutic agents in colorectal cancer patients using Irinotecan as a case study. [D] . Obeidat, Nour A. 2008

机译：以伊立替康为例的结直肠癌患者中新型化疗药物的使用和结果。
6. Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer: the C-cubed (C3) study [O] . Takeshi Nagasaka, Hideyuki Mishima, Akira Sawaki, 2016

机译：卡培他滨或5-氟尿嘧啶加奥沙利铂加贝伐珠单抗（CapeOX / mFOLFOX6-Bmab）与CapeOX / mFOLFOX6-Bmab联合治疗的序贯卡培他滨或5-氟尿嘧啶+贝伐单抗（Cape / 5-FU-Bmab）随机III期临床试验方案结直肠癌的临床研究：C-cubed（C3）研究
7. Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer [O] . 2015

机译：TRICOLORE试验的研究方案：以奥沙利铂为基础的化疗与联合用S-1，伊立替康和贝伐单抗联合化疗作为转移性结直肠癌一线治疗的III期随机研究

600 ORAL Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (ACC), an interim safety analysis. a Dutch Colorectal Cancer Group (DCCG) phase III study

著录项

引文网络

相似文献

相关主题

期刊订阅